Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
45
datasets available to search
ShareScore release 0.9.0
Dataset results
45 results for “refilling”
Single-cell RNAseq analysis (10X Genomics Chromium) of refilled lung interstium macrophages at the time points of 12h, 24h and 48h after depletion
GEO Series GSE193896. Mus musculus. 2 samples. Type: Expression profiling by high throughput sequencing.
Comparison of de novo refilled to original lung interstitial macrophages by bulk RNA-sequencing
GEO Series GSE194020. Mus musculus. 18 samples. Type: Expression profiling by high throughput sequencing.
Single-cell RNAseq analysis (10X Genomics Chromium) of refilled lung interstium macrophages on day 4 after depletion
GEO Series GSE193894. Mus musculus. 2 samples. Type: Expression profiling by high throughput sequencing.
[DATABASE] Comparing the Effectiveness, Tolerability, and Acceptability of Heated Tobacco Products and Refillable Electronic Cigarettes for Cigarette Substitution (CEASEFIRE): Randomized Controlled Trial
<p><strong>Background: </strong>People who smoke and who face challenges trying to quit or wish to continue to smoke may benefit by switching from traditional cigarettes to noncombustible nicotine delivery alternatives, such as heated tobacco products (HTPs) and electronic cigarettes (ECs). HTPs and ECs are being increasingly used to quit smoking, but there are limited data about their effectiveness.</p> <p><strong>Objective: </strong>We conducted the first randomized controlled trial comparing quit rates between HTPs and ECs among people who smoke and do not intend to quit.</p> <p><strong>Methods: </strong>We conducted a 12-week randomized noninferiority switching trial to compare effectiveness, tolerability, and product satisfaction between HTPs (IQOS 2.4 Plus) and refillable ECs (JustFog Q16) among people who do not intend to quit. The cessation intervention included motivational counseling. The primary endpoint of the study was the carbon monoxide-confirmed continuous abstinence rate from week 4 to week 12 (CAR weeks 4-12). The secondary endpoints included the continuous self-reported ≥50% reduction in cigarette consumption rate (continuous reduction rate) from week 4 to week 12 (CRR weeks 4-12) and 7-day point prevalence of smoking abstinence.</p> <p><strong>Results: </strong>A total of 211 participants completed the study. High quit rates (CAR weeks 4-12) of 39.1% (43/110) and 30.8% (33/107) were observed for IQOS-HTP and JustFog-EC, respectively. The between-group difference for the CAR weeks 4-12 was not significant (P=.20). The CRR weeks 4-12 values for IQOS-HTP and JustFog-EC were 46.4% (51/110) and 39.3% (42/107), respectively, and the between-group difference was not significant (P=.24). At week 12, the 7-day point prevalence of smoking abstinence values for IQOS-HTP and JustFog-EC were 54.5% (60/110) and 41.1% (44/107), respectively. The most frequent adverse events were cough and reduced physical fitness. Both study products elicited a moderately pleasant user experience, and the between-group difference was not significant. A clinically relevant improvement in exercise tolerance was observed after switching to the combustion-free products under investigation. Risk perception for conventional cigarettes was consistently higher than that for the combustion-free study products under investigation.</p> <p><strong>Conclusions: </strong>Switching to HTPs elicited a marked reduction in cigarette consumption among people who smoke and do not intend to quit, which was comparable to refillable ECs. User experience and risk perception were similar between the HTPs and ECs under investigation. HTPs may be a useful addition to the arsenal of reduced-risk alternatives for tobacco cigarettes and may contribute to smoking cessation. However, longer follow-up studies are required to confirm significant and prolonged abstinence from smoking and to determine whether our results can be generalized outside smoking cessation services offering high levels of support.</p>
Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock in Angers University Hospital
ClinicalTrials.gov study NCT05325957. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Bio-ADM as a Biomarker of Refilling in Chronic Hemodialysis Patient
ClinicalTrials.gov study NCT05339009. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degener
ClinicalTrials.gov study NCT05126966. IPD Sharing: YES. Countries: 7. Publications: 0.
Using Smart Phone Technology to Support HIV Medication Refill Adherence in Virginia
ClinicalTrials.gov study NCT03876626. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Transcapillary Plasma Refill in Advanced Chronic Kidney Disease
ClinicalTrials.gov study NCT03348488. IPD Sharing: NO. Countries: 1. Publications: 0.
The Effect of Synching Prescription Refills on Adherence
ClinicalTrials.gov study NCT01934608. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Restrictive Fluid Management In Liver Transplantation (REFIL)
ClinicalTrials.gov study NCT05647733. IPD Sharing: NO. Countries: 1. Publications: 0.
Intrathecal Pump Refills at Home
ClinicalTrials.gov study NCT05015933. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect Of Resuscitation Guided By Two Different Dynamic Parameters On Time To Normalization Of The Capillary Refill Time In Adult Patients With Septic Shock
ClinicalTrials.gov study NCT06122909. IPD Sharing: NO. Countries: 1. Publications: 0.
Virtual Reality During Intrathecal Pump Refills in Children
ClinicalTrials.gov study NCT04737668. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Capillary Refill Time Calculated With a Video-assisted Method Has a Better Reproducibility Than Visual Method in Critically Ill Patients
ClinicalTrials.gov study NCT05573659. IPD Sharing: NO. Countries: 1. Publications: 0.
Intrathecal Pump Refill Undergoing Regular Intrathecal Pump Refill
ClinicalTrials.gov study NCT02296515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
ClinicalTrials.gov study NCT06847542. IPD Sharing: YES. Countries: 12. Publications: 0.
Capillary Refill for Assessment of Dehydration
ClinicalTrials.gov study NCT03670394. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of the Dietary Supplement Refill Bypass to Reduce Nutritional Deficiencies of Patients Who Underwent Bariatric Surgery
ClinicalTrials.gov study NCT02440087. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2
ClinicalTrials.gov study NCT06062303. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.